H. Lee Moffitt Cancer Center
Hematology
Dr. Eric Padron, MD
|
|
Give Review
Dr. Eric Padron practices Hematology. He studied medicine at University of Florida College of Medicine. University of Florida College of Medicine has a rank of 43 in research and a 78 in primary care Eric Padron is a published doctor. He has 28 papers published. The most current publication "Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and Acute myeloid leukemia.
- Autoimmune Diseases and Myelodysplastic Syndromes.
- Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?
- Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.
- Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic Leukemia-specific biology and management strategies.
- Current State of prognostication and risk stratification in myelodysplastic syndromes.
- The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes.
- Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure: A Report on Behalf of the MDS Clinical Research...
- Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.
- The clinical management of chronic myelomonocytic Leukemia.
- Deletion 5q MDS: Molecular and therapeutic implications.
- Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in Acute myeloid leukemia from myelodysplastic syndrome after azanucleosid...
- Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?
- Mayo prognostic model for WHO-defined chronic myelomonocytic Leukemia: ASXL1 and spliceosome component mutations and outcomes.
- Validation of the revised international prognostic scoring System in treated patients with myelodysplastic syndromes.
- GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic Leukemia.
- Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes.
- Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4.
- Isolation and characterization of subgenomic DNAs encapsidated in "single" T = 1 isometric particles of Maize streak virus.
- Structure of adeno-associated virus type 4.
- Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8.
- Structurally mapping the diverse phenotype of adeno-associated virus serotype 4.
- Structure of adeno-associated virus serotype 8, a gene therapy vector.
- Fetal and neonatal habituation in infants of diabetic mothers.
- Biology and treatment of the 5q- syndrome.
- The 5q- syndrome: biology and treatment.
- Lenalidomide induces lipid raft assembly to enhance erythropoietin receptor signaling in myelodysplastic syndrome progenitors.
Schools
Univ Of Fl Coll Of Med
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
University of South Florida -
University of Florida -
University of Florida College of Medicine
Hospital
-
H. Lee Moffitt Cancer Center and Research Institute
Drug Facts
| NPI NUMBER | 1003904889 | |
| NPPES Provider LastName | PADRON | |
| NPPES Provider FirstName | ERIC | |
| NPPES Provider ZIPCode | 326103003 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 59.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003904889 |
| Last Name Of The Provider | PADRON |
| First Name Of The Provider | ERIC |
| View All |
Similar Doctors
|
Dr. Larry Kvols, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Salvador Bruno, MD |
|
Dr. Tawee Tanvetyanon, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Scott J. Antonia, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Rafael W. Blanco, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Karen K. Fields, MD |
|
|
Dr. Mohamad A. Hussein, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Asmita Mishra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew A. Fink, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Accomando, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Teruo Yamauchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Jyotishankar Raychaudhuri, MB
This Doctor is OpenDoctor Recommended.
|